Advertisement

Video

Valeant Turns Assets to Cash With $2.1 Billion in Deals

Jan.10 -- Valeant Pharmaceuticals International is selling $2.1 billion in assets in order to raise cash and ease the company's debt burden. The deals include $1.3 billion paid by L'Oreal SA for three skin-care brands. Bloomberg's Dew Armstrong has the details on "Bloomberg Daybreak: Americas."

Advertisement
Advertisement
X CLOSE